skip to main content
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients?
Material Type:
Artigo
Adicionar ao Meu Espaço

Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients?

Ballatori, E. ; Roila, F. ; Tonato, M. ; De Angelis, V. ; Riva, E. ; Barbian, P. ; Del Favero, A. ; Basurto, C. ; Ciccarese, G. ; Palladino, M. A. ; Mosconi, A. M. ; Anastasi, P. ; Picciafuoco, M. ; Campora, E. ; Chiara, S. ; Cognetti, F. ; Ferraresi, V. ; Fabi, A. ; Tonachella, R. ; Cirulli, S. ; Sabbatini, R. ; Federico, M. ; Trassoldati, A. ; Silingardi, V. ; Anna Ferrara, Arcispedale S. ; Donati, D. ; Maestri, A. ; Malacarne, P. ; Ricci, S. ; Antonuzzo, A. ; Allegrini, G. ; Conte, P. F. ; Salvati, F. ; Nunziati, F. ; Antilli, A. ; Catalano, G. ; Cascinu, S. ; Di Costanzo, F. ; Tagliaventi, M. ; Zaniboni, A. ; Meriggi, F. ; Cortesi, E. ; Ramponi, S. ; Locatelli, M. C. ; D'Antona, A. ; Santoro, A. ; Zucchinelli, P. ; Mantellim, E. ; Ferretti, G. ; Boni, C. ; Moretti, G. ; Scagliotti, G. ; Daniele, O. ; Lissoni, A. ; Tateo, S.

Annals of oncology, 1997-06, Vol.8 (6), p.561-567 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

2
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

Bracarda, S. ; Iacovelli, R. ; Boni, L. ; Rizzo, M. ; Derosa, L. ; Rossi, M. ; Galli, L. ; Procopio, G. ; Sisani, M. ; Longo, F. ; Santoni, M. ; Morelli, F. ; Di Lorenzo, G. ; Altavilla, A. ; Porta, C. ; Camerini, A. ; Escudier, B. ; Martignetti, Angelo ; Ricotta, Riccardo ; Gasparro, Donatello ; Sabbatini, Roberto ; Ceresoli, Giovanni Luca ; Mosca, Alessandra ; Santini, Daniele ; Caserta, Claudia ; Cavanna, Luigi ; Massari, Francesco ; Sava, Teodoro ; Boni, Corrado ; Verzoni, Elena ; Cartenì, Giacomo ; Hamzaj, Alketa

Annals of oncology, 2015-10, Vol.26 (10), p.2107-2113 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

3
Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study
Material Type:
Artigo
Adicionar ao Meu Espaço

Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

Caffo, O. ; Biasco, E. ; Facchini, G. ; Fratino, L. ; Gasparro, D. ; Mosillo, C. ; Basso, U. ; Santini, D. ; Tucci, M. ; Ortega, C. ; Verderame, F. ; Scagliarini, S. ; Re, G.L.o. ; Procopio, G. ; Fornarini, G. ; Campadelli, E. ; Sabbatini, R. ; Maines, F. ; De Giorgi, U.

Annals of oncology, 2016-10, Vol.27, p.vi252-vi252 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

4
Clinical outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequences in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study
Material Type:
Artigo
Adicionar ao Meu Espaço

Clinical outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequences in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

Caffo, O. ; Biasco, E. ; Facchini, G. ; Fratino, L. ; Gasparro, D. ; Mosillo, C. ; Maruzzo, M. ; Santini, D. ; Tucci, M. ; Ortega, C. ; Verderame, F. ; Scagliarini, S. ; Lo Re, G. ; Procopio, G. ; Fornarini, G. ; Campadelli, E. ; Sabbatini, R. ; Maines, F. ; De Giorgi, U.

Annals of oncology, 2016-09, Vol.27, p.iv31 [Periódico revisado por pares]

Texto completo disponível

5
790PACTIVITY OF SEQUENTIAL NEW DRUGS (NDS) POST-DOCETAXEL (DOC) FAILURE, IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS (PTS). UPDATE FROM A MULTICENTER ITALIAN EXPERIENCE
Material Type:
Artigo
Adicionar ao Meu Espaço

790PACTIVITY OF SEQUENTIAL NEW DRUGS (NDS) POST-DOCETAXEL (DOC) FAILURE, IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS (PTS). UPDATE FROM A MULTICENTER ITALIAN EXPERIENCE

Caffo, O ; De Giorgi, U ; Fratino, L ; Facchini, G ; Basso, U ; Alesini, D ; Gasparro, D ; Ortega, C ; Tucci, M ; Verderame, F ; Campadelli, E ; Re, G. Lo ; Sabbatini, R ; Donini, M ; Procopio, G ; Sartori, D ; Zucali, P.A ; Carrozza, F ; D'Angelo, A ; Morelli, F

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv273-iv274 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

6
Activity of Sequential New Drugs (Nds) Post-Docetaxel (Doc) Failure, in Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients (Pts). Update from a Multicenter Italian Experience
Material Type:
Artigo
Adicionar ao Meu Espaço

Activity of Sequential New Drugs (Nds) Post-Docetaxel (Doc) Failure, in Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients (Pts). Update from a Multicenter Italian Experience

Caffo, O. ; De Giorgi, U. ; Fratino, L. ; Facchini, G. ; Basso, U. ; Alesini, D. ; Gasparro, D. ; Ortega, C. ; Tucci, M. ; Verderame, F. ; Campadelli, E. ; Re, G. Lo ; Sabbatini, R. ; Donini, M. ; Procopio, G. ; Sartori, D. ; Zucali, P.A. ; Carrozza, F. ; D'Angelo, A. ; Morelli, F.

Annals of oncology, 2014-09, Vol.25, p.iv273 [Periódico revisado por pares]

Texto completo disponível

7
Effectiveness and possible molecular factors predictive of clinical outcomes in patients with transitional cell carcinoma of the urothelial tract (TCCU) treated with VInfluninE: a multicenter retrospective study (MOVIE) of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
Material Type:
Artigo
Adicionar ao Meu Espaço

Effectiveness and possible molecular factors predictive of clinical outcomes in patients with transitional cell carcinoma of the urothelial tract (TCCU) treated with VInfluninE: a multicenter retrospective study (MOVIE) of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)

Donini, M. ; Passalacqua, R. ; Montironi, R. ; Lazzarelli, S. ; Perrucci, B. ; Nole', F. ; Ceresoli, G.L. ; Pignata, S. ; Torriccelli, F. ; Tonini, G. ; Doni, L. ; Bernardo, A. ; Marcomini, B. ; Necchi, A. ; Betri, E. ; Degiorgi, U. ; Sabbatini, R. ; Rondini, E. ; Maiello, E. ; Caminiti, C.

Annals of oncology, 2015-10, Vol.26, p.vi53 [Periódico revisado por pares]

Texto completo disponível

8
Outcome of patients with pancreatic metastases from renal cell carcinoma: when the site matters
Material Type:
Artigo
Adicionar ao Meu Espaço

Outcome of patients with pancreatic metastases from renal cell carcinoma: when the site matters

Grassi, P. ; Doucet, L. ; Grunwald, V. ; Melichar, B. ; Galli, L. ; De Giorgi, U. ; Sabbatini, R. ; Ortega, C. ; Giglione, P. ; Santoni, M. ; Verzoni, E. ; Derosa, L. ; Studentova, H. ; Pacifici, M. ; Maggi, C. ; de Braud, F. ; Porta, C. ; Escudier, B. ; Procopio, G.

Annals of oncology, 2015-10, Vol.26, p.vi54 [Periódico revisado por pares]

Texto completo disponível

9
Outcome of patients with multiple glandular metastases from renal cell carcinoma treated with targeted agents
Material Type:
Artigo
Adicionar ao Meu Espaço

Outcome of patients with multiple glandular metastases from renal cell carcinoma treated with targeted agents

Grassi, P. ; Grunwald, V. ; Melichar, B. ; Galli, L. ; De Giorgi, U. ; Sabbatini, R. ; Ortega, C. ; Santoni, M. ; Derosa, L. ; Porcu, L. ; Ratta, R. ; Mennitto, A. ; Verzoni, E. ; de Braud, F. ; Porta, C. ; Escudier, B. ; Procopio, G.

Annals of oncology, 2016-09, Vol.27, p.iv34 [Periódico revisado por pares]

Texto completo disponível

10
Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
Material Type:
Artigo
Adicionar ao Meu Espaço

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J J ; Barrios, C H ; Kim, T M ; Cosgriff, T ; Srimuninnimit, V ; Pittman, K ; Sabbatini, R ; Rha, S Y ; Flaig, T W ; Page, R D ; Beck, J T ; Cheung, F ; Yadav, S ; Patel, P ; Geoffrois, L ; Niolat, J ; Berkowitz, N ; Marker, M ; Chen, D ; Motzer, R J

Annals of oncology, 2018-11, Vol.29 (11), p.2269-2269 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.